CPT Code 10009: Fine needle aspiration biopsy with CT guidance

Key Takeaways

CPT Code 10009 describes fine needle aspiration biopsy with CT imaging guidance for the first lesion biopsied in a session

Imaging guidance is bundled into the code descriptor and cannot be separately reported – billing a separate CT guidance code triggers NCCI edits and claim denials

Add-on code +10010 covers each additional lesion biopsied under CT guidance after the first, reported alongside 10009 by the same physician

Practice management software like Pabau captures procedure documentation – imaging modality, lesion count, specimen handling – at the point of care, so it flows into accurate invoicing and audit-ready records for CPT 10009

CPT Code 10009 describes fine needle aspiration (FNA) biopsy with CT guidance for the first lesion in a session.

Most FNA billing denials trace back to one of two errors: separately billing the imaging guidance that’s already bundled into the code, or reaching for the wrong code in the 10004-10012 series when the imaging modality differs. Knowing exactly what the code covers, what it excludes, and when to pair it with an add-on code prevents both errors.

The American Medical Association defines CPT Code 10009 as a standalone, base code in the 2019 FNA code family (10004-10012). It applies specifically when computed tomography (CT) is the imaging modality guiding needle placement.

CT guidance is most often used for deep lesions such as lung nodules, retroperitoneal masses, or complex abdominal or pelvic lesions that aren’t well visualized on ultrasound – the kind of workup ordered across oncology, general surgery, and OB/GYN practices.

The code covers a single lesion per encounter. Additional lesions require the matching add-on code.

For coders and billers at US practices, understanding the CPT Code 10009 descriptor in full is the starting point for clean claims and fewer payer rejections.

CPT Code 10009 official descriptor and key details

The official AMA descriptor for CPT Code 10009 reads: Fine needle aspiration biopsy, including CT guidance; first lesion. That single line contains three distinct billing determinants: the procedure type (FNA biopsy), the imaging modality (CT), and the lesion order (first).

One detail coders frequently miss: CPT Code 10009 is reported by the performing physician only. A radiologist performing the biopsy bills the code. A separate interventionalist or surgeon present in a consultative capacity – for instance, a plastic surgery practice called in on a complex case – does not bill 10009 for the same encounter.

The 2019 FNA code family: 10004-10012 explained

Before 2019, FNA biopsy coding was far less specific about imaging. Two legacy codes, 10021 and 10022, covered most FNA procedures, and 10022 required a separate radiological guidance code alongside it.

The AMA’s 2019 CPT revision deleted 10022 and introduced a structured family of new codes (10004-10012), each defined by imaging modality and lesion order, so guidance no longer needs a separate code.

CPT 10021 wasn’t retired – it was revised to specifically mean FNA biopsy without imaging guidance, first lesion, and it remains active and billable today.

Notice that 10005 and 10009 both cover the first lesion under imaging guidance. The distinction between them is the imaging modality, not the level of guidance documentation: 10005 applies when ultrasound guides the needle, while 10009 applies when CT guides it.

Ultrasound-guided FNA (CPT 10005) is typical for superficial, directly visualized lesions – thyroid nodules, neck masses, breast, and soft tissue. CT guidance is reserved for lesions ultrasound can’t reach or resolve well, such as lung nodules, retroperitoneal masses, and deep abdominal or pelvic lesions.

How imaging guidance is bundled into CPT Code 10009

The single most common denial trigger for FNA claims is separately billing imaging guidance. The CPT descriptor for 10009 explicitly states “including CT guidance” – the CT service is included in the code value and has already been priced into the RVU calculation by CMS.

Attempting to bill a separate CT guidance code (such as 77012) alongside CPT Code 10009 violates National Correct Coding Initiative (NCCI) bundling edits and generates an automatic claim edit.

• Do not separately bill: 77012 (CT guidance for needle placement) alongside 10009. The same logic applies across the family – don’t bill 76942 (ultrasonic guidance), 77002 (fluoroscopic guidance), or 77021 (MR guidance) alongside their corresponding FNA code.
• Imaging documentation is still required: Even though guidance is bundled, the procedure note must document that CT imaging was used, cross-sectional images were reviewed in real time, and a permanent image record was retained.
• NCCI edits apply: CMS NCCI edits pair 10009 with the CT guidance code as a bundling pair. Modifiers will generally not override these edits for the same lesion in the same session.

This bundling rule applies across the entire 10004-10012 family. Each code in the series already includes its respective guidance modality. The implication for billing: the procedure note’s documentation of imaging use supports medical necessity for the FNA code itself, not a separate guidance charge.

Accurate HIPAA-compliant clinical documentation practices protect against audits that challenge whether imaging was genuinely used.

Add-on code for additional lesions: CPT +10010

When a physician biopsies more than one lesion in the same session using CT guidance, CPT Code 10009 covers the first lesion only. Each additional lesion requires add-on code +10010, reported once per additional lesion. A session with three lesions biopsied under CT guidance would bill 10009 + 10010 + 10010.

Two important constraints apply to add-on codes. First, add-on codes can only be reported by the same physician who performed and billed the primary code.

Second, when lesions are biopsied using different imaging modalities in the same session (for example, CT for one lesion and ultrasound for another), the appropriate first-lesion code and matching add-on apply per modality, not a single add-on to 10009.

The same primary/add-on logic applies to other multi-step procedures, including IVF CPT codes.

How to choose the correct fine needle aspiration CPT code: Decision guide

Selecting the right code from the 10004-10012 series requires answering two questions in order: what imaging modality was used, and how many lesions were biopsied? A third consideration applies only when no imaging guidance was used at all.

1. Was imaging guidance used? If no: use 10021 (no imaging, first lesion), with add-on +10004 for each additional lesion. If yes: proceed to step 2.
2. Which imaging modality? Ultrasound: 10005/+10006. Fluoroscopic: 10007/+10008. CT: 10009/+10010. MR: 10011/+10012.
3. Is this the first lesion or an additional lesion? First lesion: use the standalone code (10005, 10007, 10009, 10011). Additional lesion: use the matching add-on code (10006, 10008, 10010, 10012).
4. Ultrasound (10005) or CT (10009)? This is a clinical decision, not a documentation-level one – it comes down to which modality the physician actually used to guide the needle. Ultrasound suits superficial, directly visualized lesions (thyroid, neck, breast, soft tissue); CT suits deep lesions ultrasound can’t resolve well (lung, retroperitoneal, deep abdominal or pelvic masses). Code to whichever modality the procedure note documents.

The distinction between FNA and core needle biopsy (CNB) matters here too. FNA uses a fine gauge needle (typically 22-25 gauge) to aspirate cells.

Core needle biopsy uses a larger gauge needle to extract tissue cores and is reported with different CPT codes, such as 19081-19086 for breast, 60100 for thyroid, or CPT 32408 for lung and mediastinum.

Billing CPT Code 10009 for what is actually a core needle biopsy constitutes upcoding. Coders should consult the AAPC Codify CPT lookup to verify current code descriptors before final claim submission.

CPT 10009 documentation requirements for billing

Incomplete procedure notes are the second leading cause of CPT Code 10009 denials, after the separate-guidance billing error. The procedure note must support every element of the code descriptor: FNA biopsy, CT guidance, and first lesion.

Missing any one of these documentation elements gives a payer grounds to deny or reduce reimbursement once the claim reaches the CMS-1500 form.

• Procedure type: State that the procedure is fine needle aspiration, not core biopsy or other needle-based procedure. Document gauge and number of passes.
• Imaging modality: Identify CT guidance explicitly. Document that cross-sectional images were reviewed in real time to guide the needle and that a permanent image record was saved to the patient record.
• Lesion identification: Describe each lesion by anatomical location, size, and imaging characteristics. Lesion count in the note must match the number of codes billed. If a localization device was placed to mark the lesion for subsequent surgical excision, that’s reported separately (see CPT 10035) rather than folded into the FNA code.
• Operator identity: Confirm the performing physician is the one submitting the claim. Dual-physician scenarios require clear role documentation.
• Specimen handling: Note whether material was sent for cytopathology and whether rapid on-site evaluation (ROSE) was performed. ROSE adequacy assessment is separately reportable under CPT 88172 (first evaluation episode, each site), with +88177 as the add-on for each additional adequacy episode at the same site. The final interpretation and report is billed under CPT 88173. If only a gross specimen examination is performed without microscopic evaluation, that’s billed separately under CPT 88300 instead.
• Patient consent: Document informed consent for the FNA procedure, particularly relevant for payers requiring pre-procedural consent documentation.

Practices using structured procedure forms find it easier to consistently capture these elements at the point of care rather than reconstructing them post-procedure. Retroactive addenda to procedure notes attract heightened payer scrutiny during audits.

Reduce FNA billing errors with smarter documentation

Pabau connects clinical procedure notes directly to your billing workflow, so the documentation supporting CPT Code 10009 claims is captured at the point of care. A tighter link between the procedure note and the claim means fewer denials.

Book a demo

Medicare and payer reimbursement for CPT Code 10009

Medicare reimbursement for CPT Code 10009 is set annually through the CMS Physician Fee Schedule (PFS). Rates differ by setting: the non-facility rate applies when the procedure is performed in an office or practice, while the lower facility rate applies in a hospital outpatient or ambulatory surgery center setting.

Because CT-guided FNA typically targets deep lesions (lung, retroperitoneal, abdominal, or pelvic), most of these procedures are performed in a facility setting where the facility separately bills the technical component.

Always verify the current-year rate using the CMS PFS Look-Up Tool, as rates adjust annually with RVU updates and conversion factor changes. Don’t rely on prior-year figures in billing workflows.

The FastRVU 2026 RVU lookup tool lists the Work RVU, Practice Expense RVU, and Malpractice RVU for CPT 10009 at the national level, but it doesn’t apply geographic practice cost index (GPCI) locality adjustments. For locality-adjusted Medicare payment amounts, use the CMS PFS Look-Up Tool referenced above instead.

Tracking these RVU components still helps practices benchmark reimbursement and identify underpayments from commercial payers whose contracted rates reference Medicare.

Payer policy variation is significant for this code family. Key considerations include:

• Prior authorization: Some commercial payers require pre-authorization for CT-guided FNA, particularly for lung nodule or retroperitoneal mass workup. Verify payer-specific requirements before scheduling.
• Maximum units: Some payers limit the number of add-on codes (10010) per session. A payer that allows only three lesions per session will deny a fourth unit of 10010 without an appeal.
• Global period: CPT 10009 carries a 0-day global period, meaning post-procedural care is not bundled and can be billed separately if clinically warranted.
• Pathology codes: CPT 88172 (adequacy assessment, first evaluation episode) and 88173 (interpretation and report) are separately reportable by the pathologist or cytopathologist who evaluates the specimen, with +88177 as an add-on for additional adequacy episodes at the same site – none of these are bundled with 10009.

Practices billing procedure code fee schedules across multiple payers benefit from maintaining a payer-specific billing rules reference updated at each contract renewal.

Accurate ICD-10-CM code selection on the claim also affects medical necessity determination and reimbursement outcomes – for a lung nodule workup, that often means pairing the procedure with ICD-10 R91.1.

Common coding errors and how to avoid them

FNA biopsy billing generates a predictable set of errors. Each one is preventable with the right workflow checkpoint.

• Separately billing imaging guidance: The most frequent NCCI edit trigger. Never bill 77012 alongside CPT Code 10009. The guidance is already priced into the code.
• Using 10021 for image-guided procedures: Code 10021 was revised in 2019 for non-image-guided FNA only. Billing 10021 when CT was used misrepresents the procedure and triggers a denial once the payer cross-checks the imaging documentation.
• Wrong modality code: If ultrasound guidance was used instead of CT, the correct code is 10005, not 10009. Selecting the wrong code based on procedure name alone (without checking modality) causes systematic miscoding across all cases in a series.
• Confusing FNA add-on codes across modalities: Add-on code 10010 is only valid when the primary code is 10009 (CT). Pairing 10010 with 10005 (ultrasound-guided primary) is incorrect; use 10006 for ultrasound-guided additional lesions.
• Billing 10009 for core needle biopsy: FNA codes and core needle biopsy codes are mutually exclusive for the same lesion. The procedure note must clearly state the needle type and technique.
• Missing lesion-specific documentation: Billing two units of 10009 for two lesions is not possible. The first lesion uses 10009; the second uses add-on 10010. Two units of 10009 on a single claim generates an edit.

Practices with integrated claims management software can build code-pairing validations directly into charge capture workflows, catching these errors before claims reach the payer. Fixing them post-submission requires reopened claims, appeals, and rebilling – all of which extend cash flow cycles and consume billing staff time.

Matching the ICD-10-CM code to the clinical indication also supports medical necessity for CPT 10009 claims – for a retroperitoneal biopsy, that often means pairing the procedure with the correct renal mass code.

CPT 10009 vs related fine needle aspiration CPT codes: Side-by-side comparison

Understanding where CPT Code 10009 sits within the full FNA series prevents the modality and lesion-order errors covered above. This comparison focuses on the standalone (first-lesion) codes most commonly confused with 10009.

The 10005 vs. 10009 question comes up frequently because both cover the first lesion under imaging guidance – the deciding factor is simply which modality actually guided the needle. When the procedure note documents ultrasound guidance, use 10005. When it documents CT guidance, use 10009.

Practices managing multi-procedure billing workflows benefit from maintaining a modality-to-code reference card at the charge capture point, which reduces selection errors at the source.

How Pabau supports accurate CPT 10009 billing

Billing accuracy for CPT 10009 often comes down to whether the procedure note captures the details the billing team needs, not whether coders know the rules. Practice management software like Pabau connects clinical procedure notes to invoicing workflows, so imaging modality, lesion count, and specimen handling arrive at charge capture in a structured, reviewable format.

Digital intake forms can be configured to prompt for these fields at the time of documentation, and reporting tools surface procedure frequency and revenue by CPT code, supporting the coding pattern audits that proactive billing teams run quarterly.

Conclusion

CPT Code 10009 is straightforward when its three defining elements are clear: FNA biopsy, CT guidance, first lesion. Most billing errors with this code trace back to separately billing bundled guidance, selecting the wrong modality code, or missing the lesion-level documentation that supports each billed unit.

To see how Pabau’s billing workflow fits into a full practice management setup, book a demo with the Pabau team.

Continue your research

Curious how billing works for other image-guided biopsy procedures? CPT 00702 covers anesthesia for percutaneous liver biopsy, with its own bundling and documentation rules.

Frequently Asked Questions

More CPT 10009 billing questions